Articles by Tim Burroughs
China Renaissance looks for opportunities amid turbulence
China Renaissance ended 2019 holding RMB7.2 billion ($1 billion) in dry powder across its latest flagship renminbi and US dollar-denominated funds, with the firm noting that “great investment windows typically surface during turbulent times.”
Coronavirus & take-privates: Opportunity knocks
With public equities prices sliding to multi-year lows across the region as a result of coronavirus disruption, GPs willing to take the leap might find value in privatizations
Japanese AI edge developer secures Series B funding
AISing, a Japan-based developer of edge artificial intelligence (AI) technology used in industrial robots and self-driving cars, has raised JPY700 million ($6.5 million) in Series B funding.
China's Loyal Valley recruits ex-Blackstone executive
Brian Chi, who previously spent more than a decade making China investments for The Blackstone Group and Morgan Stanley Private Equity Asia (MSPEA), has joined Loyal Valley Capital as a partner.
Alternative protein player Nature's Fynd gets $80m Series B
Nature’s Fynd, a US-based developer of edible proteins from non-animal and non-plant sources that is seen as having considerable application potential in Asia, has raised $80 million in Series B funding.
Coronavirus & leverage: Room to maneuver?
Economic disruption caused by the coronavirus outbreak is likely to leave many private equity portfolio companies in breach of their leverage covenants. Borrowers and lenders are looking for a fix
AVCJ Awards 2019: Operational Value Add: EuroKids International
Gaja Capital put its India buyout philosophy to the test with EuroKids International in 2013. Operational improvements – and a lucrative exit – have vindicated the approach
KKR appoints Asia technology investment head
Lucian Schöenefelder has been appointed head of technology investments in Asia. He previously performed a similar role for the firm in Europe.
GLP backs $1.37b take-private of Hong Kong's Li & Fung
The founders of Hong Kong-listed Li & Fung have teamed up with PE-owned warehouse operator GLP on a take-private offer that values their company at HK$10.7 billion ($1.37 billion).
Storm warning: Investors prepare for macro difficulties
The coronavirus outbreak appears to be fast-tracking a long-expected economic downturn. The situation is very different from the aftermath of the global financial crisis, but PE investors may still draw instruction from the events of 2008-2009
Village Roadshow suitors continue work despite coronavirus disruption
Pacific Equity Partners (PEP) and BGH Capital are continuing their due diligence on Australian cinema and theme park operator Village Roadshow despite the company experiencing difficulties due to coronavirus outbreak.
Korean second-hand goods marketplace gets $44m
Several Korean investors have committed KRW56 billion ($44 million) in funding to Bungaejangter, a local C2C mobile marketplace specializing in second-hand goods.
PE-backed InnoCare raises $288m in Hong Kong IPO
InnoCare Pharma, a private equity-backed Chinese drug developer focused on treatments for cancer and autoimmune diseases, has raised HK$2.24 billion ($288 million) through a Hong Kong IPO.
PE targets sensual wellness: Good vibrations
A recent commitment by China’s CDH Investments to Wow Tech underlines how sensual health products such as vibrators are moving from the margins to the mainstream, globally and in Asia
Australian LPs and co-investment: Willing partners
The difficulties NZ Super encountered with its now-defunct global direct investment unit offer pointers for Australian LPs looking at how to resource and structure co-investment programs
Burda Principal promotes Albert Shyy to Asia head
Burda Principal Investments (BPI), the investment arm of European technology and media company Hubert Burda Media, has promoted Albert Shyy to managing director and head of Asia.
Partners Group rebuffed in pursuit of Australia's Healius
Australian healthcare services provider Healius has rejected a A$2.1 billion ($1.4 billion) buyout offer from Partners Group, saying it doesn’t reflect the fundamental value of the company.
Europe's Eurazeo promotes Asian agenda
Eurazeo’s Europe-China fund – a joint effort with China Investment Corporation (CIC) and BNP Paribas – will come online at the end of this month with an initial EUR400 million ($445 million) in dry powder. It is the France-based GP’s latest milestone...
Temasek leads extended round for Singapore's ShopBack
ShopBack, a Singapore-based rewards platform that generates sales for online and offline retailers, has completed a $75 million extended round of funding led by Temasek Holdings.
CDH closes sixth China PE fund at $1.5b
CDH Investments has closed its sixth flagship US dollar-denominated fund with $1.5 billion in commitments. The initial target was $2.5 billion.
Coronavirus intensifies Asia exit, performance concerns - Bain
Asian private equity investors face considerable challenges in 2020 with the coronavirus outbreak likely to exacerbate existing concerns around an impending global downturn, a drop-off in exits and dwindling deal-making activity in China, according to...
Take-privates: Going large
Large GPs are screening public companies more carefully so they can get comfortable with elevated valuations for public-to-private deals. At what point does discomfort become the default option?
Coronavirus & fundraising: Caught in a bind
The coronavirus outbreak has implications for PE fundraising well beyond China. Many Asia-based managers are either unable to go and see LPs or LPs are not permitted to visit them
KKR looks to invest one-third of its impact fund in Asia
KKR expects to deploy one-third of its recently closed debut global impact fund in Asia and is adding dedicated resources in the region to work on deal sourcing and execution.